National Research Corporation Company Profile (NASDAQ:NRCIA)

About National Research Corporation (NASDAQ:NRCIA)

National Research Corporation logoNational Research Corporation, doing business as NRC Health, is a provider of analytics and insights for healthcare providers, payers and other healthcare organizations. The Company operates through six segments: Experience, The Governance Institute, Market Insights, Transparency, National Research Corporation Canada and Connect. The Company's portfolio of subscription-based solutions provides information and analysis to healthcare organizations and payers across a range of constituent-related elements, including patient experience and satisfaction, community population health risks, workforce engagement, community perceptions and physician engagement. NRC Health partners with clients across the range of healthcare services. The Company's clients range from integrated health systems and post-acute providers, such as home health, long-term care and hospice, to payer organizations. NRC Health's portfolio of solutions is designed to help healthcare companies.

Industry, Sector and Symbol:
  • Sector: Business Services
  • Industry: Business Support Services
  • Sub-Industry: N/A
  • Symbol: NASDAQ:NRCIA
  • CUSIP: N/A
  • Web:
  • Market Cap: $916.07 million
  • Outstanding Shares: 24,299,000
Average Prices:
  • 50 Day Moving Avg: $36.31
  • 200 Day Moving Avg: $29.01
  • 52 Week Range: $14.35 - $41.99
  • Trailing P/E Ratio: 41.52
  • Foreward P/E Ratio: 38.08
  • P/E Growth: 3.12
Sales & Book Value:
  • Annual Revenue: $114.11 million
  • Price / Sales: 8.03
  • Book Value: $3.61 per share
  • Price / Book: 10.44
  • Annual Dividend: $0.40
  • Dividend Yield: 1.1%
  • EBITDA: $39.02 million
  • Net Margins: 19.92%
  • Return on Equity: 34.22%
  • Return on Assets: 23.54%
  • Current Ratio: 1.65%
  • Quick Ratio: 1.65%
  • Average Volume: 31,162 shs.
  • Beta: 1.72
  • Short Ratio: 6.56

Frequently Asked Questions for National Research Corporation (NASDAQ:NRCIA)

What is National Research Corporation's stock symbol?

National Research Corporation trades on the NASDAQ under the ticker symbol "NRCIA."

How often does National Research Corporation pay dividends? What is the dividend yield for National Research Corporation?

National Research Corporation announced a quarterly dividend on Tuesday, September 5th. Stockholders of record on Friday, September 29th will be given a dividend of $0.10 per share on Friday, October 13th. This represents a $0.40 dividend on an annualized basis and a dividend yield of 1.06%. The ex-dividend date of this dividend is Thursday, September 28th. View National Research Corporation's Dividend History.

How were National Research Corporation's earnings last quarter?

National Research Corporation (NASDAQ:NRCIA) posted its earnings results on Tuesday, August, 4th. The company reported $0.10 EPS for the quarter, missing the consensus estimate of $0.17 by $0.07. The firm earned $24.50 million during the quarter, compared to analysts' expectations of $24 million. National Research Corporation had a return on equity of 34.22% and a net margin of 19.92%. View National Research Corporation's Earnings History.

When will National Research Corporation make its next earnings announcement?

National Research Corporation is scheduled to release their next quarterly earnings announcement on Tuesday, November, 7th 2017. View Earnings Estimates for National Research Corporation.

Where is National Research Corporation's stock going? Where will National Research Corporation's stock price be in 2017?

1 equities research analysts have issued 12 month target prices for National Research Corporation's stock. Their predictions range from $44.00 to $44.00. On average, they expect National Research Corporation's stock price to reach $44.00 in the next twelve months. View Analyst Ratings for National Research Corporation.

Who are some of National Research Corporation's key competitors?

Who are National Research Corporation's key executives?

National Research Corporation's management team includes the folowing people:

  • Steven D. Jackson, President
  • Michael D. Hays, Chief Executive Officer, Director
  • Kevin R. Karas, Chief Financial Officer, Senior Vice President - Finance, Treasurer, Secretary
  • John N. Nunnelly, Lead Independent Director
  • Donald M. Berwick M.D., Independent Director
  • JoAnn M. Martin, Independent Director
  • Barbara J Mowry, Independent Director

How do I buy National Research Corporation stock?

Shares of National Research Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is National Research Corporation's stock price today?

One share of National Research Corporation stock can currently be purchased for approximately $37.70.

MarketBeat Community Rating for National Research Corporation (NASDAQ NRCIA)
Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  48 (Vote Outperform)
Underperform Votes:  68 (Vote Underperform)
Total Votes:  116
MarketBeat's community ratings are surveys of what our community members think about National Research Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for National Research Corporation (NASDAQ:NRCIA) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Hold Rating
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $44.00 (16.71% upside)
Consensus Price Target History for National Research Corporation (NASDAQ:NRCIA)
Price Target History for National Research Corporation (NASDAQ:NRCIA)
Analysts' Ratings History for National Research Corporation (NASDAQ:NRCIA)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
2/16/2017First AnalysisDowngradeOverweight -> Equal Weight$45.00 -> $44.00N/AView Rating Details
(Data available from 10/22/2015 forward)


Earnings History for National Research Corporation (NASDAQ:NRCIA)
Earnings by Quarter for National Research Corporation (NASDAQ:NRCIA)
Earnings History by Quarter for National Research Corporation (NASDAQ NRCIA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/4/2015Q215$0.17$0.10$24.00 million$24.50 millionViewN/AView Earnings Details
5/7/2015Q115$0.20$0.08$26.00 million$26.30 millionViewN/AView Earnings Details
11/4/2014Q3 2014$0.18$0.19$24.40 million$23.68 millionViewN/AView Earnings Details
2/11/2014Q413$0.09$22.00 million$22.92 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for National Research Corporation (NASDAQ:NRCIA)
2017 EPS Consensus Estimate: $0.85
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171$0.22$0.22$0.22
Q2 20171$0.20$0.20$0.20
Q3 20171$0.21$0.21$0.21
Q4 20171$0.22$0.22$0.22
(Data provided by Zacks Investment Research)


Current Dividend Information for National Research Corporation (NASDAQ:NRCIA)
Most Recent Dividend:10/13/2017
Annual Dividend:$0.40
Dividend Yield:1.06%
Payout Ratio:76.92% (Trailing 12 Months of Earnings)
43.48% (Based on This Year's Estimates)
40.40% (Based on Next Year's Estimates)
Dividend Payments by Quarter for National Research Corporation (NASDAQ:NRCIA)

Dividend History by Quarter for National Research Corporation (NASDAQ NRCIA)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for National Research Corporation (NASDAQ:NRCIA)
No insider trades for this company have been tracked by


Headline Trends for National Research Corporation (NASDAQ:NRCIA)
Latest Headlines for National Research Corporation (NASDAQ:NRCIA)
Loading headlines, please wait.



National Research Corporation (NRCIA) Chart for Sunday, October, 22, 2017

This page was last updated on 10/22/2017 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.